Menopause The Journal of The North American Menopause Society · 2006 · 83 citations · 20 references
The lack of endometrial proliferation and improvement of climacteric complaints as well as only few gynecologic organ-related adverse events are reported for the first time after a treatment period of 1 year. Due to the improved benefit:risk ratio, it must be assumed that the Cimicifuga racemosa special extract BNO 1055 is a safe alternative for treatment of climacteric complaints.
20
Risk for breast cancer development determined by mammographic parenchymal pattern
John N. Wolfe · Cancer · 1976 · 748 citations · Full text